Home
About
FAQ
History (7)
Molecular basis of a linkage peak: exome sequencing and family-based analysis identify a rare genetic variant in the ADIPOQ gene in the IRAS Family Study.
Perhexiline
Phosphines
Jagged-1 signaling suppresses the IL-6 and TGF-ß treatment-induced Th17 cell differentiation via the reduction of ROR?t/IL-17A/IL-17F/IL-23a/IL-12rb1.
Emerging cell-cycle inhibitors for pancreatic cancer therapy.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Emerging cell-cycle inhibitors for pancreatic cancer therapy.
Bayraktar S, Rocha Lima CM. Emerging cell-cycle inhibitors for pancreatic cancer therapy. Expert Opin Emerg Drugs. 2012 Dec; 17(4):571-82.
View in:
PubMed
subject areas
Antineoplastic Agents
Cell Cycle
Cyclin-Dependent Kinases
Drug Design
Drug Resistance, Neoplasm
Humans
Pancreatic Neoplasms
Protein Kinase Inhibitors
authors with profiles
Caio Max S. Rocha Lima MD, MS